Reason for request
- Re-assessment of Actual Benefit on the transparency Committee’s own initiative in accordance with article R 163-21 of the Social Security Code and changes to Summary of Product Characteristics.
Clinical Benefit
| Moderate |
The actual benefit of AETOXISCLEROL is moderate. |
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
yH6SFQhEBbq6n0Xb
